Satohiro Masuda

12.3k total citations
191 papers, 8.8k citations indexed

About

Satohiro Masuda is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Satohiro Masuda has authored 191 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Oncology, 60 papers in Pediatrics, Perinatology and Child Health and 51 papers in Surgery. Recurrent topics in Satohiro Masuda's work include Drug Transport and Resistance Mechanisms (76 papers), Pharmacological Effects and Toxicity Studies (57 papers) and Renal Transplantation Outcomes and Treatments (49 papers). Satohiro Masuda is often cited by papers focused on Drug Transport and Resistance Mechanisms (76 papers), Pharmacological Effects and Toxicity Studies (57 papers) and Renal Transplantation Outcomes and Treatments (49 papers). Satohiro Masuda collaborates with scholars based in Japan, United States and Germany. Satohiro Masuda's co-authors include Ken‐ichi Inui, Toshiya Katsura, Hideyuki Saito, Atsushi Yonezawa, Osamu Ogawa, Masahiro Okuda, Maki Goto, Tomohiro Terada, Yumiko Urakami and Ikuko Yano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Satohiro Masuda

189 papers receiving 8.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satohiro Masuda Japan 49 4.6k 2.9k 1.9k 1.3k 1.2k 191 8.8k
Toshiya Katsura Japan 49 3.7k 0.8× 2.0k 0.7× 2.4k 1.2× 343 0.3× 698 0.6× 144 7.0k
Jatinder K. Lamba United States 41 3.6k 0.8× 2.2k 0.7× 2.1k 1.1× 1.1k 0.8× 657 0.5× 146 8.4k
Ron H. N. van Schaik Netherlands 53 2.7k 0.6× 2.2k 0.7× 2.1k 1.1× 1.5k 1.1× 1.1k 0.9× 242 9.3k
Jörg König Germany 55 8.1k 1.7× 4.2k 1.4× 2.3k 1.2× 149 0.1× 1.8k 1.5× 128 10.9k
Oliver Burk Germany 35 4.5k 1.0× 2.4k 0.8× 1.9k 1.0× 492 0.4× 821 0.7× 68 8.0k
John D. Schuetz United States 74 10.9k 2.4× 4.3k 1.5× 6.6k 3.4× 601 0.5× 2.1k 1.8× 196 19.4k
Kathrin Klein Germany 44 2.9k 0.6× 1.3k 0.4× 1.8k 0.9× 346 0.3× 586 0.5× 112 7.7k
Erin G. Schuetz United States 77 9.7k 2.1× 4.0k 1.4× 4.7k 2.4× 1.4k 1.1× 1.6k 1.4× 198 19.9k
Christian P. Strassburg Germany 59 2.2k 0.5× 1.7k 0.6× 2.9k 1.5× 458 0.3× 3.0k 2.5× 355 13.0k
Chantal Guillemette Canada 50 2.2k 0.5× 1.7k 0.6× 4.0k 2.0× 499 0.4× 557 0.5× 187 8.3k

Countries citing papers authored by Satohiro Masuda

Since Specialization
Citations

This map shows the geographic impact of Satohiro Masuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satohiro Masuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satohiro Masuda more than expected).

Fields of papers citing papers by Satohiro Masuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satohiro Masuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satohiro Masuda. The network helps show where Satohiro Masuda may publish in the future.

Co-authorship network of co-authors of Satohiro Masuda

This figure shows the co-authorship network connecting the top 25 collaborators of Satohiro Masuda. A scholar is included among the top collaborators of Satohiro Masuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satohiro Masuda. Satohiro Masuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirata, Masaaki, Shintaro Yagi, Takashi Ito, et al.. (2023). Impact of very early introduction of everolimus on liver regeneration after partial liver transplantation in rats. Journal of Hepato-Biliary-Pancreatic Sciences. 30(7). 882–892. 1 indexed citations
2.
Nies, Anne T., Jörg König, Katja Damme, et al.. (2023). Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation. Pharmacological Research. 196. 106941–106941. 4 indexed citations
3.
Lemaı̂tre, F., Klemens Budde, Teun van Gelder, et al.. (2022). Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19. Therapeutic Drug Monitoring. 45(2). 191–199. 35 indexed citations
4.
Nakagawa, Shunsaku, Ikuko Yano, Satohiro Masuda, et al.. (2022). Effect of Itraconazole and Its Metabolite Hydroxyitraconazole on the Blood Concentrations of Cyclosporine and Tacrolimus in Lung Transplant Recipients. Biological and Pharmaceutical Bulletin. 45(4). 397–402. 5 indexed citations
5.
Tajima, Soichiro, et al.. (2019). Clinical prospects of biomarkers for the early detection and/or prediction of organ injury associated with pharmacotherapy. Biochemical Pharmacology. 170. 113664–113664. 31 indexed citations
6.
Masuda, Satohiro & Yuki Yamamoto. (2018). Drug delivery system in treatment against inflammatory bowel disease: present and future. Drug Delivery System. 33(5). 397–405.
7.
Yano, Takahisa, et al.. (2017). Vancomycin induces reactive oxygen species-dependent apoptosis via mitochondrial cardiolipin peroxidation in renal tubular epithelial cells. European Journal of Pharmacology. 800. 48–56. 54 indexed citations
9.
Kamei, Hideya, Satohiro Masuda, Taro Nakamura, et al.. (2013). Association of transporter associated with antigen processing (TAP) gene polymorphisms in donors with acute cellular rejection in living donor liver transplantation.. PubMed. 22(2). 167–71. 7 indexed citations
10.
Hosohata, Keiko, Miwa Uesugi, Mio Hosokawa, et al.. (2013). Association between CYP3A5 Genotypes in Graft Liver and Increase in Tacrolimus Biotransformation from Steroid Treatment in Living-donor Liver Transplant Patients. Drug Metabolism and Pharmacokinetics. 29(1). 83–89. 17 indexed citations
11.
Kajiwara, Moto, et al.. (2012). Renal Tubular Secretion of Varenicline by Multidrug and Toxin Extrusion (MATE) Transporters. Drug Metabolism and Pharmacokinetics. 27(6). 563–569. 13 indexed citations
12.
Yoshida, Yuko, et al.. (2007). Evaluation of Immunoassay (EMIT) for Mycophenolic Acid in Comparison with High-Performance Liquid Chromatography. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 33(9). 804–808. 1 indexed citations
13.
Fukudo, Masahide, Ikuko Yano, Satohiro Masuda, et al.. (2006). Cyclosporine exposure and calcineurin phosphatase activity in living-donor liver transplant patients: Twice daily vs. once daily dosing. Liver Transplantation. 12(2). 292–300. 15 indexed citations
14.
Yonezawa, Atsushi, et al.. (2006). Cisplatin and Oxaliplatin, but Not Carboplatin and Nedaplatin, Are Substrates for Human Organic Cation Transporters (SLC22A1–3 and Multidrug and Toxin Extrusion Family). Journal of Pharmacology and Experimental Therapeutics. 319(2). 879–886. 271 indexed citations
15.
Masuda, Satohiro, Tomohiro Terada, Atsushi Yonezawa, et al.. (2006). Identification and Functional Characterization of a New Human Kidney–Specific H+/Organic Cation Antiporter, Kidney-Specific Multidrug and Toxin Extrusion 2. Journal of the American Society of Nephrology. 17(8). 2127–2135. 287 indexed citations
16.
Goto, Maki, et al.. (2004). Transient up-regulation of P-glycoprotein reduces tacrolimus absorption after ischemia–reperfusion injury in rat ileum. Biochemical Pharmacology. 69(4). 561–568. 23 indexed citations
17.
Ji, Lin, Satohiro Masuda, Hideyuki Saito, & Ken‐ichi Inui. (2002). Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy. Kidney International. 62(2). 514–524. 127 indexed citations
18.
Masuda, Satohiro, et al.. (2002). Organic Anion Transporter oatp2-Mediated Interaction between Digoxin and Amiodarone in the Rat Liver. Pharmaceutical Research. 19(6). 738–743. 42 indexed citations
19.
Inui, Ken‐ichi, Tomohiro Terada, Satohiro Masuda, & Hideyuki Saito. (2000). Physiological and pharmacological implications of peptide transporters, PEPT1 and PEPT2. Nephrology Dialysis Transplantation. 15(suppl_6). 11–13. 46 indexed citations
20.
Masuda, Satohiro, Hideyuki Saito, & Ken‐ichi Inui. (1997). Interactions of Nonsteroidal Anti-inflammatory Drugs with Rat Renal Organic Anion Transporter, OAT-K1. Journal of Pharmacology and Experimental Therapeutics. 283(3). 1039–1042. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026